01 1ALP Pharm
02 1Aurobindo Pharma Limited
03 1Charioteer
04 1Chemeca Drugs
05 1Fleming Laboratories
06 1Harman Finochem
07 1Laboratorio Chimico Internazionale Spa
08 1Polydrug Laboratories Private Limited
09 1Siegfried AG
10 1Solara Active Pharma Sciences
11 1Sun Pharmaceutical Industries Limited
12 2UQUIFA
13 1Blank
01 5CARISOPRODOL
02 1CARISOPRODOL (DRUG SUBSTANCE, NON-STERILE)
03 7CARISOPRODOL USP
04 1CARISOPRODOL USP (ACTIVE SUBSTANCE)
01 2China
02 7India
03 1Italy
04 2Spain
05 1Switzerland
06 1Blank
01 7Active
02 7Inactive
01 4Complete
02 10Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19388
Submission : 2006-04-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19919
Submission : 2006-11-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-11-05
Pay. Date : 2020-09-17
DMF Number : 35149
Submission : 2020-09-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-31
Pay. Date : 2013-01-03
DMF Number : 21064
Submission : 2007-11-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-21
Pay. Date : 2013-09-13
DMF Number : 4416
Submission : 1982-01-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5240
Submission : 1984-02-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-05
Pay. Date : 2013-03-15
DMF Number : 23100
Submission : 2009-09-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19161
Submission : 2006-02-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17444
Submission : 2004-06-03
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5181
Submission : 1983-12-27
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Carisoprodol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carisoprodol, including repackagers and relabelers. The FDA regulates Carisoprodol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carisoprodol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carisoprodol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carisoprodol supplier is an individual or a company that provides Carisoprodol active pharmaceutical ingredient (API) or Carisoprodol finished formulations upon request. The Carisoprodol suppliers may include Carisoprodol API manufacturers, exporters, distributors and traders.
click here to find a list of Carisoprodol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carisoprodol DMF (Drug Master File) is a document detailing the whole manufacturing process of Carisoprodol active pharmaceutical ingredient (API) in detail. Different forms of Carisoprodol DMFs exist exist since differing nations have different regulations, such as Carisoprodol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carisoprodol DMF submitted to regulatory agencies in the US is known as a USDMF. Carisoprodol USDMF includes data on Carisoprodol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carisoprodol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carisoprodol suppliers with USDMF on PharmaCompass.
We have 12 companies offering Carisoprodol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
